Podcast Episodes

5 6 2024

Hi, This Week in Medicine, we will be discussing

New England Journal of Medicine

Subcutaneous Administration of a Monoclonal Antibody to Prevent Malar…

2 years, 5 months ago

4 29 2024

Hi, This Week in Medicine, we will be discussing

New England Journal of Medicine

Empagliflozin after Acute Myocardial Infarction

Sequential CD7 CAR T-…

2 years, 5 months ago

4 22 2024

Hi, This Week in Medicine, we will be discussing

New England Journal of Medicine

Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma

B…

2 years, 5 months ago

4 15 2024

Hi, This Week in Medicine, we will be discussing

New England Journal of Medicine

Alectinib in Resected ALK-Positive Non–Small-Cell Lung Cancer

Trial of…

2 years, 5 months ago

4 8 2024

Hi, This Week in Medicine, we will be discussing

 New England Journal of Medicine

Omitting Axillary Dissection in Breast Cancer with Sentinel-Node Met…

2 years, 6 months ago

4 1 2024

Hi, This Week in Medicine, we will start with the article from Journal of  American Medical Association

Health Equity Adjustment and Hospital Performa…

2 years, 6 months ago

3 25 2024

Hi, This Week in Medicine, we will be discussing

New England Journal of Medicine

Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine E…

2 years, 6 months ago

3 18 2024

Hi, This Week in Medicine, we will be discussing

 New England Journal of Medicine

A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening

Next…

2 years, 6 months ago

3 11 2024

Hi, This Week in Medicine, we will be discussing

 New England Journal of Medicine

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial…

2 years, 7 months ago

3 5 2024

New England Journal of Medicine

A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis

Efficacy and Safety of Elafibranor in Primary Biliary Cho…

2 years, 7 months ago